A. Collard

发表

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults

T. Harrer, D. Podzamczer, C. Katlama, 2016, Medicine.

Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Administered Concomitantly With Diphtheria-Tetanus-Acellular Pertussis and Haemophilus influenzae Type B Vaccines to Children Less Than 2 Years of Age

M. Pichichero, H. Bernstein, D. Descamps, 2006, Pediatrics.

Immunogenicity and Reactogenicity of Primary Immunization With a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus Influenzae Type B Vaccine Coadministered With Two Doses of a Meningococcal C-Tetanus Toxoid Conjugate Vaccine

J. Roca, A. Martín-Ancel, M. Moro, 2006, The Pediatric infectious disease journal.

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.

U. Heininger, M. Knuf, K. Jahn, 2004, Vaccine.

Immunogenicity and Reactogenicity of Primary Immunization With a Novel Combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Coadministered With a Diphtheria–Tetanus–Acellular Pertussis–Hepatitis B–Inactivated Poliovirus Vaccine at 2, 4 and 6

J. Roca, A. Martín-Ancel, M. Moro, 2007, The Pediatric infectious disease journal.

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule

S. Datta, S. Chatterjee, J. Jacquet, 2010, BMC infectious diseases.

Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial

J. Jacquet, Miguel W. Tregnaghi, Á. Gentile, 2010, BMC infectious diseases.

Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.

T. Harrer, J. van Lunzen, G. Fätkenheuer, 2014, Vaccine.

Booster vaccination after neonatal priming with acellular pertussis vaccine.

C. Siegrist, M. Knuf, H. Schmitt, 2010, The Journal of pediatrics.

Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients.

G. Leroux-Roels, L. Vandekerckhove, P. Moris, 2014, Journal of immunological methods.

Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States

Stephen J. Thomas, R. Jarman, B. Innis, 2017, The American journal of tropical medicine and hygiene.

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

G. Omosa-Manyonyi, E. Chomba, J. Mpendo, 2015, PloS one.

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

I. Carletti, M. Demoitié, G. Leroux-Roels, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.

Allan C. deCamp, J. Kublin, S. Buchbinder, 2016, Current opinion in virology.